Core Viewpoint - Sanofi showcases its commitment to the Chinese market and patients by presenting its advancements in high-quality manufacturing, supply chain, immunology innovations, and patient health empowerment at the 3rd China International Supply Chain Promotion Expo [1] Group 1: Company Commitment and Achievements - Sanofi has been operating in China for over 40 years, establishing a comprehensive ecological value chain that includes local R&D, manufacturing, and patient services [1] - The year 2023 marks the 30th anniversary of Sanofi's localized manufacturing in China, highlighting its long-term commitment to the market [1] - Sanofi plans to invest €1 billion in a new production base in Beijing by December 2024, focusing on end-to-end localized production capabilities for insulin products to meet the growing demand from diabetes patients in China [1] Group 2: Supply Chain and Manufacturing Innovations - At the expo, Sanofi presented a model demonstrating the entire process of flu vaccine production, from France to local manufacturing in Shenzhen, showcasing its supply chain and manufacturing advantages [2] - The Shenzhen factory represents a significant upgrade from "manufacturing" to "intelligent manufacturing," with all key steps of flu vaccine production being localized [2] - Sanofi employs a comprehensive quality management system that ensures traceability throughout the vaccine storage and transportation process, reinforcing vaccine safety [2]

Core Viewpoint - The beauty industry is entering a new phase of "quality competition," where consumers demand high efficacy and scientific backing for products, leading to increased costs for independent research and compliance [2][4][20]. Market Demand and Consumer Expectations - Consumers are increasingly seeking products with strong efficacy supported by real foundational research, clear mechanisms of action, and professional evaluation data [4][20]. - The definition of "high quality" has evolved to include a complete research chain and robust quality control capabilities [4][20]. Industry Trends and Brand Strategies - Brands are shifting from a low-price competition model to focusing on a "boutique route," emphasizing the success rate of flagship products [6][20]. - The market is rewarding brands that possess true innovation capabilities and comprehensive research systems, enabling them to achieve high-quality long-term growth [20][27]. Supply Chain Dynamics - Traditional low-cost manufacturing firms are struggling to meet current market demands, leading to a decline in low-end production capacity [8][20]. - Supply chain companies must enhance their comprehensive strength and develop service models that align with current market needs [8][20]. Case Study: BAWI Co., Ltd. - BAWI Co., Ltd. has achieved significant growth, with projected revenue of 785 million yuan (after tax 695 million yuan) in 2024, representing a year-on-year increase of 48.24% [9][19]. - The company has developed a unique service model for full lifecycle quality management, integrating research, testing, production, marketing, and upgrades [11][20]. - BAWI's investment in research and development exceeded 30 million yuan in 2024, reflecting a 9.35% increase, and the company plans to further enhance its R&D capabilities [22][24]. Global Expansion and Market Position - BAWI Co., Ltd. has successfully expanded its overseas market presence, with revenue from international clients growing by 361.52% in 2024 [30]. - The company aims to become a benchmark in the supply chain industry by focusing on knowledge, digitalization, sustainability, and globalization [30][27].